Drug

Linzagolix clinical trials

Also written KLH-2109.

studies test it: 15
open now: 1
in phase 3: 7
first study started: 2016

Keep track of what changes. Save the linzagolix studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

75 mg linzagolix tablet: 4
200 mg linzagolix tablet: 4
Linzagolix: 3

Development codes

KLH-2109: 7
OBE2109: 1

Studies by the year they started

12 studies that test it; most in 2019 (4)

Studies that test linzagolix, by start year
Year	Studies
2016	2
2019	4
2020	2
2022	2
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 5
Phase 3: 7
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Endometriosis: 10
Leiomyoma: 2
Infertility, Female: 1

Who runs them

Industry 14 · Other 1

Kissei Pharmaceutical Co., Ltd. (11) · ObsEva SA (3) · Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita) (1)

Studies

Open first, then newest update. How each study uses linzagolix is read from its arms, and is right about nine times in ten.

Testing it · 15

Given in every arm · 2 — linzagolix is usual care beside what is tested

Codes

What other systems call linzagolix · ClinicalTrials.gg INT001614

MeSH (NLM) C000716911linzagolixConfirmed ClinicalTrials.gov, NLM
UNII (FDA) 7CDW97HUEXLINZAGOLIXConfirmed FDA, NLM
RxNorm 2621019One source FDA
NCI Thesaurus C148479LinzagolixOne source FDA

System	Code	Name there	Checked by
MeSH (NLM)	C000716911	linzagolix	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	7CDW97HUEX	LINZAGOLIX	Confirmed FDA, NLM
RxNorm	2621019	—	One source FDA
NCI Thesaurus	C148479	Linzagolix	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.